by Stacey Hawkins | Jul 21, 2016 | Infectious Disease
THE STATE OF ANTIBACTERIALS One of the greatest public health challenges of the 21st century is antibiotic resistance, which occurs when a few bacteria in a given population develop a genetic mutation that enables them to survive—even in the presence of antibiotics.... by Stacey Hawkins | May 29, 2014 | Uncategorized
MRSA’S MATCH Last week, the FDA approved Dalvance, Chicago-based Durata Therapeutic’s new antibacterial drug for the treatment of methicillin-resistant staphylococcus aureus (MRSA) infections. Why is Dalvance newsworthy? MRSA is an infectionthatis difficult to...
